A new preprint study published in the medRxiv* preprint server found that nucleocapsid antigen in the blood (antigenemia) is a sensitive and specific biomarker for acute coronavirus disease 2019 ...

A team of scientists from the University of Illinois and Northwestern University, Chicago, USA, has recently investigated and compared the efficacy of spike-based and nucleocapsid-based ...

Baseline antibody status was determined by anti-spike (primary analysis) and anti-nucleocapsid IgG assays, and staff members were followed for up to 31 weeks. We estimated the relative incidence ...

Some detect the presence of antibodies against the spike (S) protein, while others detect antibodies against the nucleocapsid (N) protein. Technology Networks spoke to Dr Iswariya Venkataraman, ...

In a small study of patients hospitalized due to SARS-CoV-2 infection, researchers report distinct early differences between the antibody responses of patients who recovered and those who died, ...

At first glance, the Ebola virus nucleocapsid looks like a coiled telephone cord. Watanabe revealed the stages of coiling and compression of the coil. She also discovered that the nucleocapsid's ...

In this Application Note, Sartorius discusses and comprehensively characterizes the interaction between the SARS-CoV-2 Nucleocapsid (N) protein (presented as the first secreted human coronavirus viral ...

The Ebola virus (EBOV) causes lethal hemorrhagic fever in humans, with extremely high morbidity and mortality. It was first discovered in two simultaneous outbreaks near the Ebola River in sub ...

San Diego-based ImmunityBio is trying to raise T-cells against both the spike and another viral protein, called the nucleocapsid, Soon-Shiong said. This could make it ideal for use as a booster ...